Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes.

Tong XingZhong-Shi LyuCai-Wen DuanHong-Yan ZhaoShu-Qian TangQi WenYuan-Yuan ZhangMeng LvYu WangLan-Ping XuXiao-Hui ZhangXiao-Jun HuangYuan Kong

Published in: Journal of translational medicine (2022)

Our results suggest that dysfunctional BM EPCs are involved in MDS patients, which indicates that improving haematopoiesis supporting ability and immuneregulation ability of BM EPCs may represent a promising therapeutic approach for MDS patients.

Keyphrases

end stage renal disease
bone marrow
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
endothelial cells